Five Prime Therapeutics: J.P. Morgan Healthcare Conference (Five Prime Therap) - Jan 14, 2016 - Anticipated data from P1b trial (NCT01868022) in 1L and previously-treated squamous NSCLC and 1L mesothelioma at ASCO (Jun 3-7, 2016)
Anticipated P1 data • Non Small Cell Lung Cancer • Oncology
|